COURTOIS-R (COUR.PA) Fundamental Analysis & Valuation

EPA:COUR • FR0000065393

Current stock price

116 EUR
+3 (+2.65%)
Last:

This COUR.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. COUR.PA Profitability Analysis

1.1 Basic Checks

  • In the past year COUR has reported negative net income.
  • COUR had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: COUR reported negative net income in multiple years.
  • In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR.PA Yearly Net Income VS EBIT VS OCF VS FCFCOUR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

  • With a Return On Assets value of -2.17%, COUR is not doing good in the industry: 63.77% of the companies in the same industry are doing better.
  • The Return On Equity of COUR (-3.30%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.17%
ROE -3.3%
ROIC N/A
ROA(3y)0.22%
ROA(5y)0.22%
ROE(3y)0.24%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
COUR.PA Yearly ROA, ROE, ROICCOUR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COUR.PA Yearly Profit, Operating, Gross MarginsCOUR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. COUR.PA Health Analysis

2.1 Basic Checks

  • COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, COUR has about the same amount of shares outstanding.
  • The number of shares outstanding for COUR has been reduced compared to 5 years ago.
  • COUR has a worse debt/assets ratio than last year.
COUR.PA Yearly Shares OutstandingCOUR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K
COUR.PA Yearly Total Debt VS Total AssetsCOUR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 1.78, we must say that COUR is in the distress zone and has some risk of bankruptcy.
  • With an excellent Altman-Z score value of 1.78, COUR belongs to the best of the industry, outperforming 84.06% of the companies in the same industry.
  • COUR has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • COUR has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. COUR outperforms 84.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC6.21%
COUR.PA Yearly LT Debt VS Equity VS FCFCOUR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • COUR has a Current Ratio of 4.15. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of COUR (4.15) is better than 88.41% of its industry peers.
  • COUR has a Quick Ratio of 2.21. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.21, COUR belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.15
Quick Ratio 2.21
COUR.PA Yearly Current Assets VS Current LiabilitesCOUR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. COUR.PA Growth Analysis

3.1 Past

  • The earnings per share for COUR have decreased strongly by -115.36% in the last year.
  • COUR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.56%.
  • The Revenue for COUR have been decreasing by -30.36% on average. This is quite bad
EPS 1Y (TTM)-115.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.46%
Revenue 1Y (TTM)9.56%
Revenue growth 3Y-38.77%
Revenue growth 5Y-30.36%
Sales Q2Q%124.25%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COUR.PA Yearly Revenue VS EstimatesCOUR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

0

4. COUR.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COUR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COUR.PA Price Earnings VS Forward Price EarningsCOUR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COUR.PA Per share dataCOUR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. COUR.PA Dividend Analysis

5.1 Amount

  • COUR has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.
  • COUR's Dividend Yield is comparable with the industry average which is at 4.13.
  • COUR's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
COUR.PA Yearly Dividends per shareCOUR.PA Yearly Dividends per shareYearly Dividends per share 2019 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
COUR.PA Yearly Income VS Free CF VS DividendCOUR.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

More info and screens

Find the best dividend stocksShow peers with best dividend

COUR.PA Fundamentals: All Metrics, Ratios and Statistics

COURTOIS-R

EPA:COUR (4/22/2026, 7:00:00 PM)

116

+3 (+2.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners78.29%
Ins Owner ChangeN/A
Market Cap8.12M
Revenue(TTM)1.57M
Net Income(TTM)-602.00K
Analysts78.82
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.17
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-8.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-32.19
FCFYN/A
OCF(TTM)-8.71
OCFYN/A
SpS22.43
BVpS260.3
TBVpS260.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -3.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.22%
ROA(5y)0.22%
ROE(3y)0.24%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4107.5%
Cap/Sales 104.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.15
Quick Ratio 2.21
Altman-Z 1.78
F-Score0
WACC6.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.56%
Revenue growth 3Y-38.77%
Revenue growth 5Y-30.36%
Sales Q2Q%124.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.15%
OCF growth 3YN/A
OCF growth 5YN/A

COURTOIS-R / COUR.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COURTOIS-R (COUR.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to COUR.PA.


What is the valuation status of COURTOIS-R (COUR.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to COURTOIS-R (COUR.PA). This can be considered as Overvalued.


Can you provide the profitability details for COURTOIS-R?

COURTOIS-R (COUR.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for COUR stock?

The financial health rating of COURTOIS-R (COUR.PA) is 6 / 10.